logo
light
search

MIMSX Holdings List NMFQS:MIMSX

Mid-Cap Blend | BNY Mellon Funds
$1.83
↑ $0.00 (0.00%)
Last Updated: Jul 08, 2026

BNY Mellon Mid Cap Multi-Strategy Fund Class Investor (MIMSX) - Mid-Cap Blend fund with $96.67 Million in assets. The fund allocates 12.24% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.

The largest holding in the fund is Dreyfus Institutional Preferred Government Plus Money Market Fund at 2.83% of total assets. This is followed by DREYFUS INSTITUTIONAL PREFERRED PL (1.42%) and AMPHENOL CORP (1.34%).

MIMSX Holdings

Name Weight Owned Change
Dreyfus Institutional Preferred Government Plus Money Market Fund 2.83% - -
DREYFUS INSTITUTIONAL PREFERRED PL 1.42% - -
AMPHENOL CORP 1.34% - -
COSTAR GROUP INC 1.20% - -
ISHARES RUSSELL MID-CAP GROWTH ETF 1.14% - -
ISHARES RUSSELL MID-CAP ETF 0.93% - -
AXON ENTERPRISE INC 0.93% - -
BURLINGTON STORES INC 0.86% - -
GARTNER INC 0.81% - -
HUBSPOT INC 0.78% - -
DREYFUS INSTITUTIONAL PREFERRED GOVERNMENT PLUS MONEY MARKET FUND 3.14% - -
Amphenol Corp 1.13% - -
HubSpot Inc 1.00% - -
Axon Enterprise Inc 0.85% - -
CoStar Group Inc 0.85% - -
AMETEK Inc 0.86% - -
Keysight Technologies Inc 0.98% - -
Pool Corp 0.80% - -
Gartner Inc 0.79% - -
Burlington Stores Inc 0.94% - -
Assurant Inc 0.82% - -
HEICO Corp 0.75% - -
IDEXX Laboratories Inc 0.86% - -
Verisk Analytics Inc 0.67% - -
Repligen Corp 0.81% - -
Vertiv Holdings Co 0.77% - -

Asset Allocation

Bond 0.00%
Cash 2.17%
Non US Stock 1.51%
Not Classified 0.00%
Other 0.00%
US Stock 96.31%

Market Cap

AverageMarketCap 20941.87%
Giant 0.04%
Large 6.55%
Medium 61.79%
Micro 2.36%
Small 26.77%

Sector Weights

Cash and Equivalents 4.10%
Corporate 4.10%
Derivative 4.10%
Government 4.10%
Municipal 4.10%
Securitized 4.10%
Basic Materials 3.60%
Consumer Cyclical 14.31%
Financial Services 11.38%
Real Estate 5.10%
Consumer Defensive 3.20%
Healthcare 12.28%
Utilities 4.10%
Communication Services 1.87%
Energy 5.69%
Industrials 21.61%
Technology 16.86%

World Regions

Latin America 0.29%
North America 98.45%
Asia Developed 0.00%
Asia Emerging 0.04%
Australasia 0.00%
Japan 0.00%
Africa/Middle East 0.21%
Europe Developed 0.77%
Europe Emerging 0.00%
United Kingdom 0.24%